Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) Fell 2.52% to 11.970
Newtimespace News, as of 11:30 on May 19, Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) was quoted at HKD 11.970, down 2.52%. The ETF opened at HKD 13.100, with a high of HKD 13.100 and a low of HKD 11.640. The latest Net Asset Value (NAV) per unit is HKD 12.268, with a premium rate of 0.10%. The asset size is approximately HKD 212 million.
Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) tracks the ChiNext Index, which is compiled and published by the Shenzhen Stock Exchange. The index consists of the 100 most representative ChiNext companies listed on the Shenzhen Stock Exchange, characterized by large market capitalization and good liquidity. Its constituent stocks are highly focused on high-tech innovation and strategic emerging industries such as electrical equipment, pharmaceuticals and biotechnology, and electronics. It is one of the core market benchmarks reflecting the development trends of China's growth-oriented and innovative entrepreneurial enterprises.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million